Showing results (71-80 of 296) with videos related to

Sort By:
Pageof 30
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 9, 2011
Nomogram to predict ipsilateral breast relapse based on pathology review from the EORTC 22881-10882 boost versus no boost trialErik van Werkhoven, Guus Hart, Harm van Tinteren, et al.
Discovery Medicine|November 2, 2010
Development of anti-cancer drugsJennifer Arrondeau, Hui K Gan, Albiruni R A Razak, et al.
Gynecologic Oncology|October 23, 2025
Survival impact of residual disease and timing of surgery in the management of advanced-stage low grade serous ovarian cancer: A systematic review and meta-analysisJudicael Hotton, Thomas Gaillard, Xavier Paoletti, et al.
The Lancet. Oncology|February 5, 2019
Towards an evidence-informed value scale for surgical and radiation oncology: a multi-stakeholder perspectiveYolande Lievens, Riccardo Audisio, Ian Banks, et al.
European Journal of Cancer (Oxford, England : 1990)|June 3, 2006
Using the continual reassessment method: lessons learned from an EORTC phase I dose finding studyXavier Paoletti, Benoît Baron, Patrick Schöffski, et al.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2017
Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer ConsortiumFrancisco Bautista, Lucas Moreno, Lynley Marshall, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 17, 2015
Coronary stenosis risk analysis following Hodgkin lymphoma radiotherapy: A study based on patient specific artery segments dose calculationAlexandra Moignier, David Broggio, Sylvie Derreumaux, et al.
Biometrical Journal. Biometrische Zeitschrift|September 17, 2020
A new measure of treatment effect in clinical trials involving competing risks based on generalized pairwise comparisonsEva Cantagallo, Mickaël De Backer, Michal Kicinski, et al.
Biometrical Journal. Biometrische Zeitschrift|February 22, 2021
Correcting the bias of the net benefit estimator due to right-censored observationsJulien Péron, Maryam Idlhaj, Delphine Maucort-Boulch, et al.
The Oncologist|December 28, 2014
Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinomaMomar Diouf, Franck Bonnetain, Jean-Claude Barbare, et al.
Pageof 30